AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 273: H1894-H1902, 1997;
0363-6135/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meng, X.
Right arrow Articles by Harken, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meng, X.
Right arrow Articles by Harken, A. H.
Vol. 273, Issue 4, H1894-H1902, October 1997

LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha

Xianzhong Meng, Lihua Ao, James M. Brown, Daniel R. Meldrum, Brett C. Sheridan, Brian S. Cain, Anirban Banerjee, and Alden H. Harken

Department of Surgery, University of Colorado Health Sciences Center, Denver, Colorado 80262

Lipopolysaccharide (LPS) and tumor necrosis factor (TNF)-alpha independently induce cardioprotection against ischemia in the rat at 24 h after administration, suggesting that endogenously synthesized TNF-alpha may play a role in LPS-induced protection. The purposes of this study were 1) to delineate the time course of LPS-induced cardiac functional protection against ischemia and its relation with myocardial and circulating TNF-alpha profile, 2) to examine whether prior protein synthesis inhibition abrogates the protection, and 3) to assess the effects of TNF-alpha inhibition and neutralization on the protection. Rats were treated with LPS (0.5 mg/kg ip). Cardiac functional resistance to normothermic global ischemia-reperfusion was examined at sequential time points after LPS treatment in isolated hearts by the Langendorff technique. Myocardial and circulating TNF-alpha was determined by enzyme-linked immunosorbent assay at 1-24 h after LPS treatment. Protection was apparent at 24 h, 3 days, and 7 days but not at 2 or 12 h. Maximal protection at 3 days was abolished by cycloheximide pretreatment (0.5 mg/kg ip 3 h before LPS treatment). Increases in myocardial and circulating TNF-alpha preceded the acquisition of protection. Dexamethasone pretreatment (4.0 or 8.0 mg/kg ip 30 min before LPS treatment) abolished peak increase in myocardial TNF-alpha and substantially suppressed circulating TNF-alpha (54.3 and 85.9% inhibition, respectively) without an influence on the maximal protection. Similarly, maximal protection was not affected by TNF binding protein (40 or 80 µg/kg iv immediately after LPS treatment). The results suggest that LPS-induced cardiac functional protection against ischemia is a delayed and long-lasting protective response that may involve de novo protein synthesis. Although LPS-induced increase in myocardial and circulating TNF-alpha precedes the delayed protection, it may not be required for the delayed protection.

ischemia-reperfusion; cycloheximide; dexamethasone; tumor necrosis factor binding protein; rat


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Feng, H. Zhao, X. Xu, E. S. Buys, M. J. Raher, J. C. Bopassa, H. Thibault, M. Scherrer-Crosbie, U. Schmidt, and W. Chao
Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1311 - H1318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhu, H. Zhao, A. R. Graveline, E. S. Buys, U. Schmidt, K. D. Bloch, A. Rosenzweig, and W. Chao
MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1900 - H1909.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. A. R. C. Daemen, V. H. Heemskerk, C. van 't Veer, G. Denecker, T. G. A. M. Wolfs, P. Vandenabeele, and W. A. Buurman
Functional Protection by Acute Phase Proteins {alpha}1-Acid Glycoprotein and {alpha}1-Antitrypsin Against Ischemia/Reperfusion Injury by Preventing Apoptosis and Inflammation
Circulation, September 19, 2000; 102(12): 1420 - 1426.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. B. Cowan, D. N. Poutias, P. J. Del Nido, and F. X. McGowan Jr
CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin
Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H619 - H629.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S.-H. Ahmed, Y. Y. He, A. Nassief, J. Xu, X. M. Xu, C. Y. Hsu, and F. M. Faraci
Effects of Lipopolysaccharide Priming on Acute Ischemic Brain Injury Editorial Comment
Stroke, January 1, 2000; 31(1): 193 - 199.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belosjorow, R. Schulz, H. Dorge, F. U. Schade, and G. Heusch
Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2470 - H2475.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. K. Donnahoo, X. Meng, A. Ayala, M. P. Cain, A. H. Harken, and D. R. Meldrum
Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R922 - R929.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. D. Shames, D. R. Meldrum, C. H. Selzman, E. J. Pulido, B. S. Cain, A. Banerjee, A. H. Harken, and X. Meng
Increased levels of myocardial Ikappa B-alpha protein promote tolerance to endotoxin
Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H1084 - H1091.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
X. Meng, J. M. Brown, L. Ao, R. T. Rowland, S. K. Nordeen, A. Banerjee, and A. H. Harken
Myocardial gene reprogramming associated with a cardiac cross-resistant state induced by LPS preconditioning
Am J Physiol Cell Physiol, August 1, 1998; 275(2): C475 - C483.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Meng, L. Ao, D. R. Meldrum, B. S. Cain, B. D. Shames, C. H. Selzman, A. Banerjee, and A. H. Harken
TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R502 - R508.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online